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fluid flow-induced osteogenesis in osteocytes 
Introduction 
 
One scenario in which the adult skeleton adapts to ex-
ternal stimulation is by generating more bone in re-
sponse to heightened forces. This load-induced bone 
formation appears to be coordinated by osteocytes, the 
sensory cells in bone that serve as signaling centers for 
osteogenesis. Skeletal maintenance and adaptation is 
therefore dependent on osteocyte mechanotransduc-
tion, or the process of converting physical stimulation 
into intracellular signaling cascades. Osteocytes are 
embedded in cortical bone, residing in fluid-filled 
pockets (lacunae) connected via microscopic channels 
(canaliculi). One prevailing theory for osteocyte mech-
anotransduction proposes that physical loading gener-
ates fluid flow through the lacunar/canalicular system, 
resulting in shear stresses that act on osteocytes. In this 
model it is believed that fluid shear triggers activation 
of osteogenic pathways within the osteocyte, but the 
exact mechanisms required for osteocyte stimulation 
remain an important open question. 
 One mechanism by which osteocytes trans-
duce mechanical stimuli is through the primary cilium, 
a solitary sensory organelle that projects from the cell 
surface. The primary cilium bends in response to fluid 
shear in vitro and contains a unique microdomain of 
proteins and signaling molecules that enhance mecha-
notransduction. For example, the predominant model 
for kidney cilia exposed to fluid flow is that the cilium 
bends and calcium (Ca2+) enters the cilium through a 
transmembrane protein, polycystin 1 (PC1), interacting 
with a Ca2+ channel, polycystin 2 (PC2). Our lab re-
cently determined that osteocyte primary cilia experi-
ence a similar flow-induced Ca2+ influx and this is 
critical to osteogenesis, a cellular response that eventu-
ally elicits bone formation. However, osteocyte ciliary 
Ca2+ influx does not occur through the PC1/PC2 com-
plex (Lee et al. 2015). We previously identified an-
other Ca2+ channel, Transient Receptor Potential Va-
nilloid 4 (TRPV4), is present in the osteocyte cilium 
and knockdown of TRPV4 attenuates flow-induced 
osteogenesis (Lee et al. 2015). TRV4 is also highly 
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Bone adapts to physical forces and this process is de-
pendent on osteocyte mechanotransduction. One way 
osteocytes sense mechanical stimulation is through the 
primary cilium, a sensory organelle that triggers intra-
cellular signaling cascades in response to fluid shear. 
Our lab previously determined that flow-induced 
ciliary Ca2+ influx and changes in cytosolic cAMP lev-
els are critical for osteogenesis. We also identified two 
proteins important for osteocyte mechanotransduction: 
transient receptor potential vanilloid 4 (TRPV4) and 
adenylyl cyclase 6 (AC6). Interestingly, disrupting the 
Ca2+-binding ability of these proteins results in loss of 
function. Although knockdowns of TRPV4 and AC6 
disrupt osteogenesis, there is no definitive evidence 
linking them to Ca2+/ cAMP dynamics that facilitate 
osteocyte mechanotransduction. We therefore trans-
fected MLO-Y4 osteocytes with AC3/6 and TRPV4 
overexpression plasmids that fail to interact with Ca2+ 
and observed the response to fluid shear. Indeed, mu-
tant groups exhibited adverse changes in cAMP and 
lower mRNA expression of an osteogenic marker, 
COX-2, at the onset of flow. This pattern persisted for 
AC3 and TRPV4 but we detected no difference in AC6 
at longer exposure to flow. These results suggest 
TRPV4 and ACs mediate Ca2+/ cAMP dynamics that 
are important for osteocyte mechanotransduction. 
These mechanisms are potential targets for therapeu-
tics to combat bone loss and should be investigated 
further. 
Abstract 
expressed in the primary cilium of mesenchymal stem 
cells (MSCs) and necessary for fluid shear-induced 
calcium signaling and subsequent osteogenic gene ex-
pression in these cells (Corrigan et al. 2018). Interest-
ingly, MSCs lacking primary cilia were unresponsive 
to pharmacological activation of TRPV4 that was 
found to enhance osteogenesis (Corrigan et al. 2018). 
We therefore speculate that, in response to fluid shear, 
Ca2+ perhaps enters the osteocyte cilium through the 
opening of TRPV4 channels. 
 Previous studies have established that TRPV4 
must bind Ca2+ to activate intracellular Ca2+ influx, a 
process that is critical to the function of bone cells. 
Strotmann et al. initially determined that TRPV4 is 
potentiated by Ca2+ interacting with a C-terminal cal-
cium-modulated protein – known as Calmodulin 
(CaM) - domain (Strotmann et al. 2003). When this 
CaM domain is removed, TRPV4-mediated Ca2+ entry 
does not occur. Another group implemented this muta-
tion and determined that osteoclasts, which are acti-
vated to resorb bone, remained inactive in vitro when 
the CaM domain was absent (Masuyama et al. 2008). 
Moreover, mice containing this mutation demonstrated 
enhanced bone formation in vivo due to attenuated os-
teoclast activation (Masuyama et al. 2012). A recent 
study proposed that fluid shear initiates osteocyte 
mechanotransduction in a microtubule-dependent 
mechanism involving TRPV4-mediated Ca2+ entry 
(Lyons et al. 2017). Combined with the aforemen-
tioned experiments in MSCs, these studies suggest 
TRPV4 interacts with Ca2+ to trigger Ca2+-mediated 
intracellular signaling and can potentially be pharma-
cologically targeted to enhance osteogenesis. 
 A second key difference from kidney cells is 
that osteocyte primary cilia contain unique adenylyl 
cyclases (ACs). ACs convert ATP to cyclic AMP 
(cAMP), a signaling molecule that is downregulated in 
osteocytes at the onset of fluid shear and elevated for 
longer durations of flow (Kwon et al. 2010). There are 
nine transmembrane isoforms of AC but only AC6 is 
believed to localize to the osteocyte cilium and is not 
found in kidney cilia (Kwon et al. 2010). We previ-
ously demonstrated that osteocytes containing siRNA-
mediated knockdowns of AC6 maintained cytosolic 
levels of cAMP with fluid shear, resulting in attenu-
ated osteogenesis (Kwon et al. 2010). This finding is 
consistent with osteocytes containing an siRNA-
mediated knockdown of Ift88, a protein critical for 
cilium presence and function. Furthermore, transgenic 
mice with a global knockout of AC6 exhibit attenuated 
load-induced bone formation (Lee et al. 2014) similar 
to mice lacking primary cilia in osteoblasts, also 
known as bone-forming cells (Temiyasathit et al. 
2012). Interestingly, AC6-mediated production of 
cAMP is inhibited by Ca2+, whereas other ACs, such 
as AC3, are activated by Ca2+ to produce cAMP (Halls 
& Cooper 2011). Initial decreases in cAMP production 
can perhaps be attributed to Ca2+ inhibition of AC6, 
but the eventual increase in cAMP levels alludes to a 
separate mechanism, such as Ca2+-excitable AC3. De-
spite the building evidence correlating Ca2+ and cAMP 
dynamics in the cilium, there is no definitive evidence 
or mechanism to link the two. 
 TRPV4, AC3, and AC6 all contain Ca2+ bind-
ing domains that can be disrupted through genetic mu-
tations. Extracellular Ca2+ binds to a calcium-
modulated protein (calmodulin, CaM) domain of 
TRPV4, causing this channel to open and trigger Ca2+ 
entry in the cell (Strotmann et al. 2003). This CaM 
domain can be removed by eliminating 17 residues 
without disrupting general TRPV4 function 
(Strotmann et al. 2003). Indeed, this mutation was 
found to inhibit calcium influx in and subsequent acti-
vation of osteoclasts, the cells responsible for remov-
ing bone (Masuyama et al. 2012). Protein binding ex-
periments revealed that AC5 competitively binds Ca2+ 
via a domain conserved between AC5 and AC6, and 
its ability to produce cAMP is inhibited in the bound 
state (Hu et al. 2002). Another group used x-ray crys-
tallography to identify two aspartic acid residues that 
are critical for AC6 to fold and form the binding 
pocket (Mou et al. 2009). Mutation of these two resi-
dues renders AC6 unable to bind calcium and it contin-
ues to catalyze the conversion of ATP to cAMP. This 
binding pocket is conserved in AC3, but is activated 
by Ca2+ to produce cAMP (Halls & Cooper 2011). 
Thus, in contrast to AC6, disrupting AC3’s binding 
pocket prevents cAMP production. Although these 
mutations are well defined, they have yet to be ex-
plored in the context of the primary cilium or osteocyte  
mechanotransduction. 
 Overall, it is largely unknown how Ca2+ and 
cAMP operate in the primary cilium and what role, if 
any, AC6 plays in mechanotransduction. We hypothe-
size that fluid flow bends osteocyte primary cilia, trig-
gering Ca2+ entry through TRPV4 channels. We fur-
ther anticipate that in the early initiation of flow, Ca2+ 
binds to AC6 and AC3 to inhibit and enhance produc-
tion of cAMP, respectively, resulting in upregulation 
of osteogenic markers. The objectives of this study are 
to determine whether 1) Ca2+-mediated opening of 
TRPV4 is critical to osteogenesis and 2) AC6 and AC3 
mediate flow-induced Ca2+/ cAMP dynamics.  
 
Materials and Methods 
 
Plasmid design and construction 
Entry clones for murine AC6 (MmCD00297230) and 
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human AC3 (HsCD00505998) in pENTR223.1 vectors 
were obtained from the DNASU Plasmid Repository. 
AC6 and AC3 entry clones were inserted into a 
pcDNA3.2 mammalian expression destination vector 
(12489019, Life Technologies) using the Gateway LR 
Clonase System (Life Technologies) to generate 
pcDNA3.2 + AC6 (AC6 OE) and pcDNA3.2 + AC3 
(AC3 OE) overexpression plasmids. This kit provides 
a reaction control entry clone, GWCAT, to generate a 
pcDNA3.2 + GWCAT overexpression vector. Trans-
fection alone alters normal cell behavior so pcDNA3.2 
+ GWCAT (Control OE) was used as a control, rather 
than untransfected cells, for all experiments. All of our 
pcDNA3.2 plasmids have a V5 tag at the end of the 
inserted protein. 
 Mutation of the AC calcium binding pocket 
has been previously described (Hu et al. 2002, Mou et 
al. 2009) and was generated here via site directed 
mutagenesis. Specifically, we identified the two 
charged aspartic (Asp) acid residues responsible for 
calcium binding (Mou et al. 2009) and performed 
point mutations to convert them to neutral alanine 
(Ala) residues. These residues are located in the 324th 
and 368th positions for AC3 and the 382nd and 426th 
positions for AC6. PCR was performed on the AC3 
and AC6 OE plasmids using custom designed mutation 
primers to convert the Asp residues to Ala (Table 1). 
Resulting PCR product was ligated and transformed 
using the Q5 Site-Directed Mutagenesis Kit (New 
England Biolabs). Plasmids were isolated from bacte-
ria using a QIAprep Spin Miniprep Kit (Qiagen). The 
resulting plasmids are pcDNA3.2 + AC3Ala 324, 368 
(AC3 Mut OE) and pcDNA3.2 + AC6Ala 382, 426 (AC6 
Mut OE) overexpression plasmids that contain AC3 
and AC6 that cannot bind calcium, respectively. 
 OE plasmid contains TRPV4 flagged with a 
yellow fluorescent protein (YFP) tag in a pcDNA3.1 
vector. Removal of the CaM domain has been previ-
ously described (Masuyama et al. 2008, 2012) and was 
generated using the aforementioned site directed 
mutagenesis protocol with published primer sequences 
(Masuyama et al. 2012). The pcDNA3.1 and 
pcDNA3.2 vectors have negligible differences that will 
not affect this experiment; thus, pcDNA3.2 + GWCAT 
(Control OE) was also used as a vector control for all 
TRPV4 experiments. All constructed plasmids and 
sequence mutations were confirmed using Sanger se-
quencing (Genewiz) and custom primers (Integrated 
DNA Technologies) (Table 1). 
 
Cell culture 
MLO-Y4s were passaged at least twice before used for 
experiments, seeded on Type I Collagen coated dishes 
or glass slides, and cultured in MEMα supplemented 
with 5% FBS, 5% CS, and 1% PenStrep (Life Tech-
nologies). Cells were cultured in reduced serum media 
(MEMα supplemented with 2.5% FBS, 2.5% CS, and 
0.5% P/S) 48 hours prior to fluid flow. MLO-Y4s did 
not reach over 60% confluence in standard passage, 
but were grown to reach at least 80% confluence for 
fluid flow studies. Cells transfected with AC6 OE or 
AC6 Mut OE were cultured in MLOY4 media supple-
mented with 600 ug/mL Geneticin (Life Technologies) 
for 48 hours the day after electroporation, followed by 
48 hours of reduced serum media. AC3 OE and AC3 
Mut OE specimens received reduced serum media for 
48 hours the day after electroporation. AC3 and AC6 
plasmids were cultured for a total of 3 and 5 days, re-
spectively, before experimentation since this is when 
each plasmid demonstrated peak protein expression 
(Figure 1). Passages 38 - 48 were used for all experi-
ments. 
 
Transfections 
For each transfection, 1.25 million MLO-Y4s were 
suspended in 250 µL of BTX Buffer (Harvard Appara-
tus). Plasmid DNA was added to the cells in BTX so-
lution and gently flicked to mix, then transferred to a 4 
mm gap cuvette for electroporation. The amount of 
plasmid DNA added was normalized to copy number; 
therefore, AC3 OE/ AC3 Mut OE/ AC6 OE/ AC6 Mut 
OE/ TRPV4 OE/ TRPV4 Mut OE specimens received 
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Plasmid Mutation Primers Sequencing Primer 
AC3 Mut OE 
  
324 For: TCCTCTTTGCCGCCATCG 
324 Rev: TGCTGACGTTCTCGTGACG 
368 For: TTAAGATCCTGGGCGCCTGC 
368 Rev: TCCGCAGCTGGTGGTATTTAGC 
For: TCTATGACGGTGATGGTGTTCC 
AC6 Mut OE 
  
382 For: TTGAGGGCTTCACCAGCCTG 
382 Rev: TGGCCGCAAACAGGATGCTG 
426 For: TAGGAGCCTGTTACTACTGC 
426 Rev: AGATCTTGATCCTCAGACAG 
For: TGTCTGCACACACTACCCTG 
TRPV4 Mut OE 
For: CTTCTCCCTGAACAAGAACTCAAGC 
Rev: TTGTTCAGGGAGAAGCCATAGTACTG 
For: TCTCTACCACTGACACCCGTTC 
Table 1. Mutation and sequencing primers for mutation plasmid design 
15 µg and the GWCAT Control OE group received 7 
µg per transfection. Cells were transfected via electro-
poration using a BTX ECM 360 Electro Cell Manipu-
lator (Harvard Apparatus) to generate a single pulse 
with settings: 300 V, 100 Ω, 1000 µF. Cells remained 
in BTX buffer for no more than 10 minutes to mini-
mize cell death. The resulting electroporation solution 
was split between 4 glass slides for fluid flow studies 
or 4 100 mm tissue culture dishes for Forskolin treat-
ment. 10 µL of electroporation solution was seeded on 
35 mm glass bottom dishes for immunocytochemistry. 
Cells were rinsed and media was changed the morning 
after a transfection to remove dead cells. 
 
Forskolin treatment 
Transfected cells were cultured to achieve peak protein 
expression and treated with 10 µM Forskolin (Sigma) 
dissolved in DMSO (Sigma) or vehicle control for 20 
minutes at 37°C. After treatment, cells were lysed us-
ing 1 mL of 0.1 M HCl (cAMP ELISA kit, Enzo) for 
10 minutes at room temperature and centrifuged at 4°C 
for 15 min at 16 rcf. The resulting supernatant was 
transferred to a fresh tube for the cAMP assay. 
 
Immunocytochemistry (ICC) 
To determine plasmid expression patterns, double ICC 
was performed to detect AC3/AC6 and V5 tag of the 
destination vector. Cells were fixed with 4% parafor-
maldehyde for 10 min at room temperature and 
blocked with 3% BSA + 2% goat serum + 0.1% Tri-
tonX-100 (Sigma) in PBS for 1 hour at room tempera-
ture. Cells were then incubated in primary antibodies 
against V5 (1:500, Life Technologies) and either AC3 
(1:1000, FabGennix) or AC6 (1:1000, abcam) for one 
hour on a rocker at room temperature. The fluorescent 
secondary antibodies, Alexa Fluor 488 (1:500, Life 
Technologies) and AlexaFluor 568 (1:500, Life Tech-
nologies) were applied for 1 hour at room temperature 
to detect V5 and AC3/AC6, respectively. Nuclei were 
detected using NucBlue ReadyProbes (Life Technolo-
gies). 
 To examine cilia incidence/length, double ICC 
for V5 and primary cilia was performed. The same 
procedure was repeated with primary antibodies 
against V5 (1:500, Life Technologies) and Arl13b 
(1:1000, Protein Tech), a protein localized to cilia. 
Cells were then left overnight on a rocker at 4°C, fol-
lowed by the addition of secondary antibodies. All 
fluorescent images were collected using an Olympus 
Fluoview FV1000 confocal microscope and software. 
 
Quantifying cilium incidence and length 
At minimum 4 images per dish containing at least 25 
nuclei were analyzed to determine the average inci-
dence and length per specimen (dish). Each transfec-
tion was performed on 3 separate occasions to evaluate 
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Figure 1. MLO-Y4s containing our overexpression vectors demonstrate supranormal protein levels. ICC for V5 (green) re-
vealed that MLO-Y4s transfected with GWCAT OE (A, bottom), AC3 OE (B, top), and AC6 OE (B, bottom) overexpress 
GWCAT, AC3, and AC6 protein, respectively. TRPV4 expression was confirmed by visualizing YFP (green) (A, top). AC3 
and AC6 are pictured in red (B, middle). Nuclei are pictured in blue. Images were collected at 20X. This experiment was per-
formed 3 times for each group.  
repeatability and consistency between trials. Once cells 
reached a minimum of 80% confluence, cilium inci-
dence and length were measured manually from confo-
cal stacks using Image J software. Specifically, indi-
vidual nuclei and their associated cilia (one per nu-
cleus) were identified and the number of cilia was di-
vided by the total number of nuclei to calculate inci-
dence. The individual cilia were then visualized in 3D 
stacks and length was determined using measurement 
tools in Image J to count the number of pixels along 
the axoneme. Length and incidence were averaged for 
each image field and considered a sample (n). Investi-
gators were blinded to the groups during the experi-
ment, staining, image acquisition, and post-imaging 
analysis steps. Quantifications were performed by two 
investigators to ensure repeatability and accuracy of 
reported results. Manual quantifications were validated 
using custom Matlab algorithms for incidence and 
length intended for lower magnification fields contain-
ing hundreds of nuclei. 
 
Oscillatory fluid flow (OFF) 
Transfected MLO-Y4s were seeded on glass slides 
(Fisher Scientific; 75 x 38 x 1 mm). Upon reaching 
80% confluence, cells were placed in parallel-plate 
flow chambers (56 × 24 × 0.28 mm), incubated at 37°C 
for 30 minutes at rest, and exposed to 2, 5, or 30 min-
utes of OFF at 1 Hz with a peak shear stress of 10 dyn/
cm2. For RT-qPCR analysis, samples were incubated 
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Figure 2. Ca2+ binding pocket disruption does not influence 
general AC catalytic activity. MLO-Y4s were transfected 
with AC3 (yellow) and AC6 (green) or their corresponding 
mutation overexpression plasmids and treated with forsko-
lin. Compared to vehicle controls, all specimens demon-
strated an approximate 2-fold increase in cAMP production. 
This increase was comparable between OE plasmids and 
their Mut OE counterparts, as well as between AC3 and 
AC6 specimens. Data are normalized to vehicle controls 
and reported as the mean ± SEM. n = 5 for AC3 specimens, 
n = 6 for AC6 specimens. This experiment was performed 3 
times for each group. 
Figure 3. Osteocyte primary cilia lengthen with increased AC6 protein expression. Cilia were identified in transfected MLO-
Y4s using double ICC for V5 (green) and Arl13b, a protein that localizes to cilia (red). Cell nuclei are pictured in blue. Visu-
ally, cilia appeared to be longer in AC6 OE (B) and AC6 Mut OE samples (not pictured) compared to Control OE (B). Three 
dimensional stacks were collected at 100X magnification using a confocal microscope. Cilia incidence and length were meas-
ured manually using Image J software. Indeed, AC6 and AC6 Mut OE demonstrated longer cilia (C) but this effect was not 
present in AC3 and TRPV4 OE samples. Data are presented as mean ± SEM, **p < 0.001. Control n = 15, OE n = 12, Mut OE 
n = 12. This experiment was performed 3 times. 
for 1 hour (2 and 5 min OFF studies) or 30 min (30 
min OFF studies) post-flow and were removed from 
the chambers, rinsed in cold PBS, and lysed immedi-
ately with 1 mL TriReagent (Sigma Aldrich) to isolate 
RNA. For cAMP quantification studies, 0.5 mM of the 
phosphodiesterase inhibi tor  3 -isobutyl -1-
methylxanthine (IBMX) (Sigma) was added to flow 
media to prevent cAMP degradation. At the conclusion 
of flow, samples were rinsed and lysed immediately 
with 500 µL of 0.1 M HCl (cAMP ELISA kit, Enzo) 
for 10 minutes. The resulting lysate was centrifuged at 
4°C for 15 min at 16 rcf and the supernatant was trans-
ferred to a fresh microcentrifuge tube. 
 
mRNA quantification 
RT-qPCR was performed to quantify flow-induced 
changes in Cyclooxygenase-2 (COX-2), an indicator of 
flow-induced osteogenesis, and GAPDH, a housekeep-
ing gene known to maintain consistent mRNA levels, 
using fluorescent primers (Life Technologies) and an 
ABI 
PRISM 7900 (Applied Biosystems). Samples were 
performed in triplicate and COX-2 was normalized to 
GAPDH expression levels. OFF samples were normal-
ized to static controls to calculate fold change.  
 
cAMP ELISA 
Cytosolic cAMP levels were quantified using a kit 
from Enzo Life Sciences (ADI-900-163). Samples 
were analyzed in triplicate and prepared according to 
the manufacturer’s instructions for non-acetylated 
samples in hydrochloric acid lysis buffer. cAMP levels 
were normalized to total protein content of the lysate, 
which was determined by a Pierce BCA Protein Assay 
(Thermo Fisher). OFF samples were normalized to 
static controls to calculate fold change. 
 
Statistics 
It was concluded that data satisfy the requirements of 
normality and the variance of statistically compared 
groups was similar. Data were analyzed using a one-
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Figure 4. Flow-induced changes in cAMP levels and COX-2 expression in osteocytes overexpressing intact and mutated AC3. 
MLO-Y4s were transfected with AC3 OE, AC3 Mut OE, or Control OE plasmids and exposed to 2 or 30 min OFF. The AC3 
Mut OE group exhibits decreased cAMP levels (A, B) and enhanced osteogenesis (C, D) compared to AC3 OE. Bar graphs 
represent fold changes with OFF compared to static controls. AC3 OE and AC3 Mut OE are normalized to Control OE. Data 
are presented as mean ± SEM. n = 6 for all groups, **p < 0.001, ***p < 0.0001. These experiments were performed 3 – 4 times 
for each group. 
stains on cells transfected with Control OE, AC3 OE, 
or AC3 Mut OE. For both AC3 plasmids, 80 – 90% of 
the cells overexpressed AC3 protein 3 days PT (Figure 
4.1B). Cells transfected with the Control OE plasmid 
demonstrated greater than 90% efficiency 3 days PT 
(Figure 4.1A) and maintained expression for 5 days 
PT. The mutation plasmids exhibited identical expres-
sion patterns as their non-mutated plasmids (data not 
shown). For these reasons, AC3 and TRPV4 experi-
ments were performed 3 days PT, while AC6 studies 
were conducted 5 days PT. Moreover, we considered 
the GWCAT plasmid an acceptable empty vector con-
trol at both time points. 
 
AC3 and AC6 catalytic activity is maintained when 
the calcium binding pocket is disrupted 
The catalytic activity of both AC3 and AC6 is sensi-
tive to Ca2+, but all ACs are activated by the AC ago-
nist forskolin at an independent binding site. We there-
fore treated transfected MLO-Y4s with forskolin to 
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way ANOVA followed by Bonferroni post-hoc correc-
tion, or a two-tailed student’s t-test. Values are re-
ported as mean ± SEM, with p < 0.05 considered sta-
tistically significant. Sample size was determined to 
achieve a power of at least 80%.   
 
Results 
 
Transfected MLO-Y4s overexpress TRPV4, AC3, 
and AC6 protein 
We first determined whether our constructed plasmids 
would result in supranormal levels of AC3, AC6, and 
TRPV4 protein. For the TRPV4 plasmids, we visual-
ized YFP in live cells and determined that more than 
90% of cells overexpressed the protein 3 days post-
transfection (PT) (Figure 4.1A). Double ICC for V5 
and AC6 revealed that only 20 – 30% of transfected 
cells overexpressed AC6 3 days PT. We therefore im-
plemented antibiotic selection and achieved 100% effi-
ciency 5 days PT (Figure 4.1B). We repeated these 
Figure 5. Flow-induced changes in cAMP levels and COX-2 expression in osteocytes overexpressing intact and mutated AC6. 
MLO-Y4s were transfected with AC6 OE, AC6 Mut OE, or Control OE plasmids and exposed to 2 or 30 min OFF. After 2 
min of OFF, the AC6 Mut OE group exhibits an increase in cAMP production (A) and decreased osteogenic response (C) com-
pared to the AC6 OE group. There is no difference in cAMP production (B) or COX-2 expression (D) between the groups with 
30 min of OFF. Bar graphs represented fold changes with OFF compared to static controls. AC6 OE and AC6 Mut OE are nor-
malized to Control OE. Data are presented as mean ± SEM. n = 6 for all groups, *p < 0.01. These experiments were repeated 3 
times for each group. 
confirm that our mutations do not disrupt general AC 
activity. Indeed, AC3/6 Mut OE specimens demon-
strated increased cAMP levels that were comparable to 
AC3/6 OE groups, indicating AC activity is preserved 
(Figure 2). This result importantly confirms that any 
changes in cAMP production in the mutant groups are 
direct consequences of disrupting the Ca2+ binding 
pocket. AC activity in MLO-Y4s transfected with 
AC3/ Mut OE plasmids (p < 0.001) and AC6/ Mut OE 
plasmids (p < 0.01) was elevated compared to the Con-
trol OE group, simply because these cells contain more 
AC protein. 
 
Cilium length increases with overexpression of AC6 
Recent work in our lab suggests MLO-Y4s with longer 
cilia have an enhanced osteogenic response to fluid 
shear (Spasic & Jacobs, 2017). We therefore sought to 
determine whether cilium incidence or length in-
creased when these osteocyte ciliary proteins were 
overexpressed. Interestingly, cilia length increased 
only with AC6 normal and mutant overexpression 
(Figure 3). AC3/ Mut OE (p = 0.634) and TRPV4/ Mut 
OE (p = 0.133) elicited no change compared to vector 
controls. We did not detect any differences in cilium 
incidence between any of the groups (Supplementary 
Figure 1). 
 
Disrupting the calcium binding pocket of AC3 and 
AC6 alters flow-induced cAMP production 
We then investigated how cytosolic cAMP levels 
change when the Ca2+ binding pockets of AC3 and 
AC6 are disrupted. Transfected cells were exposed to 2 
min and 30 min of oscillatory fluid flow (OFF), in ac-
cordance with our previous work (Kwon et al. 2010), 
and AC OE groups were normalized to Control OE 
groups. Normally, osteocytes exhibit decreased levels 
of cytosolic cAMP production after 2 min of flow. In-
deed, cells transfected with AC3 Mut OE produced 
less cAMP than the AC3 OE group (Figure 4A), 
whereas the AC6 Mut OE group exhibited increased 
levels compared to AC6 OE (Figure 5A). We have 
previously shown that cAMP levels then increase after 
30 min of flow (Kwon et al., 2010). After 30 min OFF, 
the AC3 Mut OE group demonstrated lower cAMP 
levels compared to AC3 OE (Figure 4B). Interestingly, 
there was no significant difference between AC6 OE 
and AC6 Mut OE groups (Figure 5B), which exhibited 
cAMP levels similar to the Control OE group (p = 
0.116).  
 
Osteogenesis is attenuated when cAMP production 
is altered 
We then evaluated changes in flow-induced osteogene-
sis to identify how cAMP production may influence 
the osteocyte’s response to fluid shear. Specifically, 
we quantified expression of cyclooxygenase-2 (COX-
2), a common readout and surrogate for osteocyte os-
teogenesis. In response to fluid shear, MLO-Y4s nor-
mally demonstrate an increase in COX-2 (Hoey et al. 
2012, Kwon et al. 2010). Cells transfected with AC3 
Mut OE had enhanced osteogenesis compared to AC3 
OE at both timepoints examined (Figure 4C, D). AC6 
Mut OE had an attenuated osteogenic response com-
pared to AC6 OE, but only when flow was applied for 
2 min (Figure 5C, D). There was no significant differ-
ence between AC6 OE and AC6 Mut OE groups, 
which exhibited COX-2 readouts similar to the Control 
OE (p = 0.215) group with 30 min of flow. Overall, the 
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Figure 6. Osteocytes demonstrate attenuated flow-induced osteogenesis when the CaM domain of TRPV4 is removed. 
MLOY4s were transfected with TRPV4 OE, TRPV4 Mut OE, or Control OE plasmids and exposed to 5 or 30 min OFF. The 
TRPV4 Mut OE group has an attenuated COX-2 response compared to the TRPV4 OE group. Bar graphs represented fold 
changes with OFF compared to static controls. TRPV4 OE and TRPV4 Mut OE data are normalized to Control OE data. Data 
are presented as mean ± SEM. n = 6 for all groups, *p < 0.01, **p < 0.001. These experiments were performed 3 times for each 
group.  
data indicate that osteocyte osteogenesis is influenced 
by AC-mediated cytosolic cAMP production. 
 
Osteogenesis is attenuated when the TRPV4 CaM 
domain is removed 
Finally, we investigated changes in flow-induced os-
teogenesis when intact and mutated TRPV4 are over-
expressed. We exposed cells transfected with TRPV4 
OE and TRPV4 Mut OE to 5 and 30 min of flow in 
accordance with timepoints examined in our initial 
studies (Kwon et al. 2010, Lee et al. 2015). Regardless 
of flow duration, cells overexpressing TRPV4 Mut OE 
had an attenuated response to flow compared to the 
TRPV4 OE group. Interestingly, MLOY4s transfected 
with TRPV4 OE had an enhanced COX-2 response 
compared to the Control OE group (p < 0.05). 
 
Discussion 
 
These studies demonstrate, for the first time, that Ca2+ 
and cAMP are perhaps coupled via adenylyl cyclases 
in osteocytes. AC3 and AC6 have long been known to 
bind Ca2+ to modify cAMP production (Halls & Coo-
per 2011), but the purpose of this mechanism remains 
poorly characterized in the context of cell behavior. 
AC5/6 expression and activity are important for proper 
heart development and function (Gao et al. 2017, Hu et 
al. 2009) and AC5, which is also inhibited by Ca2+, is 
critical to Ca2+-mediated cardiac regulation (Okumura 
et al. 2003). AC3 is present in many tissue types and 
known to bind free Ca2+ to stimulate cAMP production 
(Xia et al. 1992), but the cellular function of this phe-
nomena remains largely unknown. Our lab previously 
identified that, in response to fluid flow, mecha-
notransduction is initiated when Ca2+ enters the MLO-
Y4 primary cilium (Lee et al. 2015) and cytosolic 
cAMP levels decrease (Kwon et al. 2010). We further 
demonstrated that an siRNA-mediated knockdown of 
AC6 inhibits MLO-Y4 osteogenesis (Kwon et al. 
2010), and mice containing a global knockout of AC6 
exhibit attenuated load-induced bone formation (Lee et 
al. 2014). We therefore suspected that ACs mediate 
Ca2+ entry and subsequent cAMP production in osteo-
cytes. To determine whether ACs associated with the 
primary cilium mediate Ca2+/ cAMP dynamics during 
osteocyte mechanotransduction, we disrupted the Ca2+ 
binding pocket of AC3/6 and evaluated flow-induced 
cAMP production and COX-2 expression. Indeed, os-
teocytes containing disrupted forms of AC3/6 demon-
strated conflicting cAMP production compared to their 
functional counterparts. Furthermore, osteocytes with 
higher levels of cytosolic cAMP (AC3 OE and AC6 
Mut OE) exhibited attenuated flow-induced osteogene-
sis. Our results suggest AC3 and AC6 are present in 
the osteocyte and bind Ca2+ to mediate cytosolic 
cAMP production to facilitate mechanotransduction. 
 Moreover, our data imply cAMP levels can 
perhaps be tuned to enhance osteocyte osteogenesis. 
Our previous work suggests that cytosolic cAMP lev-
els decrease at the onset of flow (2 min OFF) and in-
crease after 30 min of OFF (Kwon et al. 2010), but we 
currently observed that COX-2 levels increase for both 
flow durations (Figures 4-5). Interestingly, the AC3 
OE group, which increased cAMP production, had a 
significantly attenuated osteogenic response compared 
to the Control OE group after 2 min of OFF (p < 0.01). 
Moreover, COX-2 expression was diminished in the 
AC3 Mut OE group compared to Control OE (p < 
0.05) after 30 min OFF. These results are consistent 
with our prior findings and indicate that decreased cy-
tosolic cAMP levels are important for the initial onset 
of fluid flow, whereas elevated cAMP production is 
required for osteogenesis after a longer duration of 
flow. Although COX-2 levels were slightly elevated in 
the AC6 OE group after 2 min OFF, overexpressing 
the AC6 plasmids did not result in any significant 
changes compared to controls. Our prior work suggests 
MLO-Y4s normally contain more AC3 than AC6 pro-
tein, so these cells are perhaps more sensitive to ele-
vated cytosolic AC3 expression. It is also probable that 
AC3 OE cells produced more AC protein than AC6 
OE cells, given that we achieved the desired efficiency 
48 hours faster with the AC3 plasmids. Another possi-
bility is that since AC3 is activated to produce cAMP, 
whereas AC6 is merely inhibited, the excitatory behav-
ior had a more drastic impact on normal MLO-Y4 
cAMP production.  
 This work also further implicates TRPV4 as 
the mechanism by which Ca2+ enters the osteocyte dur-
ing mechanotransduction. A recent study established 
that fluid shear elicits Ca2+ influx in osteocytes via 
TRPV4 and proposed that this Ca2+ channel is an im-
portant target for enhancing bone quality (Lyons et al., 
2017). Moreover, a prior study conducted by our lab 
revealed that an siRNA-mediated knockdown of 
TRPV4 uniquely resulted in attenuated osteogenesis in 
MLOY4s (Lee et al. 2015). We also determined that 
knockdown of PC2, the predominant Ca2+ channel in 
kidney cilia, does not influence osteocyte mecha-
notransduction. In the work presented here, we showed 
that MLOY4s with supranormal TRPV4 protein levels 
had an enhanced osteogenic response at both short and 
long-term flow exposure. However, when these cells 
overexpressed TRPV4 that could not facilitate Ca2+ 
entry into the cell or cilium, the enhanced osteogenic 
response was lost. This phenomena has also been ob-
served in osteoclasts, which require the same TRPV4 
CaM domain to be activated for bone resorption 
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(Masuyama et al. 2012). Collectively, these results 
perhaps suggest that overall bone maintenance relies 
on TRPV4-mediated activation of osteocytes and os-
teoclasts, which promote and reduce bone formation, 
respectively. More importantly, they demonstrate that 
expression of proteins associated with mechanotrans-
duction can be engineered to influence osteocyte-
mediated osteogenesis.   
 AC6 is an attractive therapeutic target for bone 
regeneration since it is potentially unique to osteocyte 
cilia. Our prior work suggests AC6 is the only AC pre-
sent in the osteocyte cilium and its existence is unique 
compared to kidney cilia (Kwon et al. 2010). Our 
group and others have also shown that pharmacologi-
cally lengthening cilia enhances the cell’s response to 
fluid-flow and this phenomenon is correlated with in-
creased AC6 expression (Besschetnova et al. 2010, 
Spasic & Jacobs 2017). It is unknown how lengthening 
enhances osteogenesis but one possibility is that more 
proteins associated with mechanotransduction are 
available since the cilium is larger. Additionally, the 
longer axoneme may sense flow more readily and 
more easily bend to form a stress concentration at its 
base. In this study, we demonstrated that only MLO-
Y4s overexpressing AC6, not AC3 or TRPV4, had 
longer cilia. This favors the hypothesis that cilia may 
lengthen due to increased AC6 availability. Although 
we identified that TRPV4 is potentially the predomi-
nant Ca2+ channel in osteocytes, TRPV4 is also impor-
tant for osteoclast activation (Masuyama et al. 2008, 
2012). Thus, non-targeted therapeutic strategies that 
manipulate TRPV4 could simultaneously activate bone 
formation and resorption. Similarly, AC3 is present in 
many cell types so any manipulation would need to be 
targeted to avoid negative side effects. Additionally, 
AC3 overexpression alone influenced osteogenesis. 
The primary cilium tunes its response to physical stim-
uli in order to prevent overstimulation (Nguyen et al. 
2015). This is an important negative-feedback mecha-
nism inherent to cilium function, so therapeutic strate-
gies should not interfere with this adaptation. There is 
also evidence that AC3 only binds Ca2+ after it has 
been activated in order to enhance cAMP production, 
but definitive proof is lacking (Halls & Cooper 2011). 
If this is true, targeting AC3 may not facilitate the 
ciliary Ca2+/cAMP dynamics critical to mechanotrans-
duction. 
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Figure 7. Proposed Ca2+/ cAMP dynamics involving the osteocyte primary cilium microdomain. (A) summary of ciliary pro-
teins and the effects of Ca2+ binding. (B) Cartoon depicting our hypothesis of Ca2+/ cAMP dynamics in the osteocyte primary 
cilium. We propose that, in the initial onset of fluid shear, the cilium bends (1) and extracellular Ca2+enters the osteocyte cil-
ium by binding TRPV4 to facilitate opening of this channel, resulting in a ciliary influx of Ca2+ (2). The Ca2+ that enters the 
cilium then binds to AC6 (3), inhibiting production of cAMP (4).  
 Although AC6 did lengthen osteocyte cilia, we 
did not detect a significant difference in COX-2 ex-
pression compared to controls after 2 and 30 min of 
OFF. In prior studies, cells were stimulated for an hour 
(Besschetnova et al. 2010, Spasic & Jacobs 2017) so 
increased AC6 expression may require longer flow 
exposure to impact the cells. It is also possible that our 
plasmids generated too much cytosolic AC6 protein 
and interfered with cAMP production or other cellular 
processes. This contradiction highlights a potential 
limitation in our study, which is utilizing CMV-driven 
overexpression plasmids to explore ciliary proteins. 
Expression vectors conveniently allow for the study of 
protein alterations in mammalian cells, but overex-
pressing protein is not always physiologically relevant. 
More importantly, these vectors stimulate supranormal 
protein levels in the cytosol, so we are unable to di-
rectly observe their function in the primary cilium. 
Thus, it is possible that overexpressing AC6 specifi-
cally in the primary cilium is critical to observe 
changes in flow-induced COX-2 expression. Despite 
this limitation, we were still able to demonstrate that 
ACs mediate Ca2+/ cAMP dynamics and subsequent 
osteogenesis. Our lab recently developed novel cilium-
targeted biosensors that we will next use to specifically 
characterize Ca2+/ cAMP dynamics in the cilium. We 
intend to combine these biosensors with the now avail-
able CRISPR technology to overexpress, mutate, or 
eliminate AC3, AC6, and TRPV4 specifically in the 
cilium. 
 Collectively, the results from this study build 
on prior work (Kwon et al. 2010, Lee et al. 2014, 
2015, Spasic & Jacobs 2017) to suggest that AC6 and 
TRPV4 are important for the immediate onset of flow-
induced osteocyte mechanotransduction. We now 
speculate that, when exposed to flow, the osteocyte 
cilium bends and extracellular Ca2+ binds to the CaM 
domain of TRPV4 (Figure 4.7). TRPV4 then opens 
and Ca2+ enters the cilium, potentially in the direction 
from the ciliary base to the axoneme tip (Lee et al. 
2015). Ciliary Ca2+ binds to AC6, which is then unable 
to catalyze the conversion of ATP to cAMP. Conse-
quently, cytosolic cAMP levels decrease since existing 
cAMP is recruited for flow-induced intracellular sig-
naling and AC6 is inhibited from replenishing cAMP. 
AC3 is perhaps important at a later stage of fluid flow 
stimulation, when cAMP levels increase to encourage 
osteogenesis. 
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